Patient-Reported Outcome-Based Symptom Management Vs Usual Care
“Compared with usual care (UC), patient-reported outcome (PRO)-based symptom management can...
Read MoreFeb 25, 2022
“Compared with usual care (UC), patient-reported outcome (PRO)-based symptom management can...
Read MoreFeb 24, 2022
1. This prospective cohort study demonstrated that, in adult patients with active cancer and a...
Read MoreFeb 23, 2022
1. Cancer biosimilar treatment trials have clinical outcomes that do not differ statistically from...
Read MoreFeb 23, 2022
1. Compared to population- and sibling-matched cohorts, women previously diagnosed with cervical...
Read MoreFeb 22, 2022
1. Olaparib led to a bigger decrease in pain interference and symptomatic skeletal-related events...
Read MoreFeb 16, 2022
1. The median progression-free survival for trametinib was significantly greater than that for...
Read MoreFeb 15, 2022
1. Patients receiving pembrolizumab with or without platinum-based chemotherapy experienced longer...
Read MoreFeb 15, 2022
1. Overall, the influence of religion and spirituality on treatment decision making was both...
Read MoreFeb 15, 2022
1. In a large retrospective study, rates of venous thromboembolism (VTE) in pediatric patients...
Read MoreFeb 15, 2022
1. Overall survival is longer in patients treated with cemiplimab as compared to chemotherapy. 2....
Read More